Todd C. Brady

Companies

• Aldeyra Therapeutics, Inc.Board member May 1, 2014 to now¹
• Aldeyra Therapeutics, Inc.Chief executive officer May 1, 2014 to now¹
• Aldeyra Therapeutics, Inc.President May 1, 2014 to now¹
• Evoke Pharma IncBoard member Sep 24, 2013 to now²
• F-star Therapeutics, Inc.Board member Jul 29, 2016 to Mar 9, 2023³
• Avidity Biosciences, Inc.Board member Jun 11, 2020 to Jun 11, 2020⁴
• Outlook Therapeutics, Inc.Board member May 12, 2016 to Oct 30, 2017⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAldeyra Therapeutics, Inc. ALDX1,721,298 shares⁶$1.3M at $0.76Jun 3, 2026
• EPEvoke Pharma Inc0 shares⁷Dec 16, 2025
• FSF-star Therapeutics, Inc.0 shares⁸Mar 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 3, 2026Bought 250,000 shares at $1.67 of Aldeyra Therapeutics, Inc.⁶
• Dec 16, 2025U 27 shares of Evoke Pharma Inc⁷
• Mar 12, 2024Sold 85,324 shares at $3.05 of Aldeyra Therapeutics, Inc.⁹
• Mar 11, 2024Sold 97,914 shares at $3.27 of Aldeyra Therapeutics, Inc.⁹
• Sep 7, 2023Shares withheld for tax 73,807 shares at $7.22 of Aldeyra Therapeutics, Inc.¹⁰
• Sep 7, 2023Exercised options 48,021 shares at $0.55 of Aldeyra Therapeutics, Inc.¹⁰
• Sep 7, 2023Exercised options 32,953 shares at $0.55 of Aldeyra Therapeutics, Inc.¹⁰
• Sep 7, 2023Exercised options 192,084 shares at $0.55 of Aldeyra Therapeutics, Inc.¹⁰
• Mar 8, 2023U 15,004 shares at $7.12 of F-star Therapeutics, Inc.⁸
• Feb 28, 2023Granted 238,750 shares of Aldeyra Therapeutics, Inc.¹¹
• Jun 23, 2022Bought 17,700 shares at $3.36 of Aldeyra Therapeutics, Inc.¹²
• Mar 30, 2022Granted 250,000 shares of Aldeyra Therapeutics, Inc.¹³